CME Group

CME · NASDAQ

$295.31+$1.78 (+0.61%)TodayMarket closed ·
Prev close $293.53

About CME

CME Group, Inc. operates a derivatives marketplace, which offers a range of futures and options products for risk management. The company is headquartered in Chicago, Illinois and currently employs 3,875 full-time employees. The company went IPO on 2002-12-06. The firm enables clients to trade futures, options, cash and over the counter (OTC) markets, optimize portfolios, and analyze data. The company exchanges offer a range of global benchmark products across all major asset classes based on interest rates, equity indexes, foreign exchange (FX), energy, agricultural products and metals. The company offers futures and options on futures trading through the CME Globex platform, fixed income trading via BrokerTec and FX trading on the EBS platform. In addition, it operates central counterparty clearing provider, CME Clearing. Its products provide a means for hedging, speculation and asset allocation related to the risks associated with, among other things, interest rate sensitive instruments, and changes in the prices of agricultural, energy and metal commodities. The company provides clearing and settlement services for a range of exchange-traded futures and options on futures contracts and OTC derivatives.

Employees
3,875
Headquarters
Chicago, Illinois
Listed
Dec 6, 2002
Sector
Financials
Industry
Capital Markets

CME key statistics

Market cap
105.55B
Price-earnings ratio
24.90
Dividend yield
3.86%
Average volume
1.94M
Volume
2.36M
Open price
$296.39
High today
$299.92
Low today
$293.30
52 Week high
$329.16
52 Week low
$218.31

CME Group (CME) at a glance

CME Group (CME) last traded at $295.31, with a market cap of 105.55B, a price-to-earnings ratio of 24.90 and a dividend yield of 3.86%.

Today the stock has traded between $293.30 and $299.92. The current price is 0.7% above the day's low and 1.5% below its high.

Volume so far is 2.36M shares, above the average of 1.94M shares a day.

Over the past year CME Group has ranged from $218.31 to $329.16, and now sits 69% of the way up that range.

CME Group met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY26 it reported $2.99 per share against an estimate of $2.94.

The average analyst price target is $291.61, 1.3% below the current price, from 15 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

47%of 15 analyst ratings say Buy
  • Buy46.7%
  • Hold40.0%
  • Sell13.3%
Price target · 17 analystsAvg $291.61
Low
$232.30
Now
$295.31
High
$346.50

CME earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 1.3% on average.

  1. Q3 FY24: reported $2.68 per share against an estimate of $2.68
  2. Q4 FY24: reported $2.52 per share against an estimate of $2.47
  3. Q1 FY25: reported $2.80 per share against an estimate of $2.84
  4. Q2 FY25: reported $2.96 per share against an estimate of $2.95
  5. Q3 FY25: reported $2.68 per share against an estimate of $2.66
  6. Q4 FY25: reported $2.77 per share against an estimate of $2.77
  7. Q1 FY26: reported $3.36 per share against an estimate of $3.40
  8. Q2 FY26: reported $2.99 per share against an estimate of $2.94

CME news

  • Press releasePRNewswire

    CME Group Announces First Trade for Bitcoin Cash and Uniswap Futures

  • Press releasePRNewswire

    China's Treasury Pile Is Shrinking on Paper. The Custody Data Tell a Different Story

  • Press releasePRNewswire

    CME Group Expands Dairy Business with New European Futures and Options

  • Press releasePRNewswire

    CME Group to Launch Tungsten Futures to Meet Rising Demand for Critical Minerals

  • Press releasePRNewswire

    CME Group's Corn Futures Set New Daily Volume Record After USDA Raised Outlook

  • Press releasePRNewswire

    CME Group Announces Cloud Migration Milestones

  • Press releasePRNewswire

    CME Group to Launch World's First Baseball Futures on October 12

  • Press releasePRNewswire

    CME Group's International Average Daily Volume Rises 22% to 9 Million Contracts in Q3 2026

Similar companies

Companies in the same industry as CME Group

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.